IP in the Life Sciences Industries 2014 – Canada

Key issues for senior life sciences executives

Deciding whether to proceed with litigation or to forgo or settle an infringement claim requires that a broad number of factors be carefully weighed

By Brad Jenkins, J Bradley Whiteand Vincent de Grandpré, Osler Hoskin & Harcourt LLP

To read the full article please follow the link below.


Links